Bonesupport Holding AB (publ) (FRA:2B4)

Market Cap	1.22B -34.3%
Revenue (ttm)	116.18M +21.1%
Net Income	19.32M +44.6%
EPS	0.29 +44.6%
Shares Out	n/a
PE Ratio	63.22
Forward PE	32.41
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54
Open	18.55
Previous Close	18.64
Day's Range	18.55 - 18.55
52-Week Range	15.50 - 30.66
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 16, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone gra...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 171
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2B4

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 28, 2026

Data Sources Report a data error